Cargando…
The unexpected science of estrogen receptor-β selective agonists: a new class of anti-inflammatory agents?
In the nine years since the unexpected discovery of a second form of the estrogen receptor (ER), ERβ has been mentioned in about 2,800 literature citations. Such prolific research is testimony to interest in explaining its role in estrogen physiology as well as investigating its potential as a drug...
Autor principal: | Harris, Heather A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Nuclear Receptor Signaling Atlas
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513066/ https://www.ncbi.nlm.nih.gov/pubmed/16862218 http://dx.doi.org/10.1621/nrs.04012 |
Ejemplares similares
-
Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists
por: Paruthiyil, Sreenivasan, et al.
Publicado: (2009) -
Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013) -
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016) -
Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury
por: Ray, Swapan K., et al.
Publicado: (2016) -
Evidences of hydroxytyrosol as an anti-inflammatory agent in Parkinson’s disease: insights into the mechanisms of action
por: Hornedo-Ortega, Ruth, et al.
Publicado: (2020)